Cargando…
MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative bacteria (GNB) including Klebsiella pneumoniae. Although it happens rarely, resistance to colistin has been reported for several GNB. A total of 20 colistin resistant (col-R) and three colistin suscepti...
Autores principales: | Haeili, Mehri, Javani, Afsaneh, Moradi, Jale, Jafari, Zeinab, Feizabadi, Mohammad M., Babaei, Esmaeil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741654/ https://www.ncbi.nlm.nih.gov/pubmed/29326662 http://dx.doi.org/10.3389/fmicb.2017.02470 |
Ejemplares similares
-
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae
por: Yap, Polly Soo-Xi, et al.
Publicado: (2022) -
Prevalence and epidemiological investigation of mgrB-dependent colistin resistance in extensively drug resistant Klebsiella pneumoniae in Iran
por: Zahedi Bialvaei, Abed, et al.
Publicado: (2023) -
MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission
por: Bray, Andrew S., et al.
Publicado: (2022) -
The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran
por: Haeili, Mehri, et al.
Publicado: (2018) -
Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
por: Al-Farsi, Hissa M., et al.
Publicado: (2019)